Recombinant Human Melanoma Antigen Preferentially Expressed In Tumors Protein (1-509Aa)
Alternative Names:
4930534P07Rik, Cancer/testis antigen 130, CT130, MAPE, Melanoma antigen preferentially expressed in tumors, OIP 4, OIP-4, OIP4, OPA interacting protein 4, Opa interacting protein OIP4, OPA-interacting protein 4, PRAME, PRAME_HUMAN, Preferentially expressed antigen in melanoma, Preferentially expressed antigen of melanoma, RP23-250F8.3
The Prame Polyclonal Antibody is applicable for the following applications: ELISA, IHC. Host: Rabbit. Species Reactivity: Human (Homo sapiens). Immunogen: Recombinant Human Melanoma Antigen Preferentially Expressed In Tumors Protein (1-509Aa). Accession Number: P78395. Target Synonyms: 4930534P07Rik, Cancer/testis antigen 130, CT130, MAPE, Melanoma antigen preferentially expressed in tumors, OIP 4, OIP-4, OIP4, OPA interacting protein 4, Opa interacting protein OIP4, OPA-interacting protein 4, PRAME, PRAME_HUMAN, Preferentially expressed antigen in melanoma, Preferentially expressed antigen of melanoma, RP23-250F8.3. Restrictions: For Research Use Only. Not for use in diagnostic procedures.
Clonality:
Polyclonal
Concentration:
Lot specific. Please inquire or refer to the datasheet included in the product pouch.
